Regenxbio (RGNX) Capital Expenditures (2015 - 2025)
Regenxbio (RGNX) recorded Capital Expenditures of $508,000 in Q4 2025, down 52.9% from $1.08 million a year earlier but up 3.5% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Capital Expenditures (2015 - 2025) Analysis & Trends
For FY2025, Regenxbio reported Capital Expenditures of $2.41 million, down 0.9% from FY2024.
- Annual Capital Expenditures has declined for four straight years, with a five-year compound annual growth rate of -38.2% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $2.44 million in FY2024 (-75.5%), $9.96 million in FY2023 (-67.6%), $30.72 million in FY2022 (-63.5%) and $84.18 million in FY2021 (+213.3%).
- Quarterly Capital Expenditures has ranged from $326,000 in Q3 2024 to $31.02 million in Q1 2021 over the past five years.
- On a year-over-year basis, Capital Expenditures rose in two of the last eight quarters, with an average decline of 23.4%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 570.0% in Q1 2021, against a decline of 88.4% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $491,000 (Q3 2025), $391,000 (Q2 2025) and $1.02 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Regenxbio | 407.85 Mn | -525.24 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 508,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 326,000.00 |
| Jun 30, 2024 | 474,000.00 |
| Mar 31, 2024 | 557,000.00 |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 2.58 Mn |
| Mar 31, 2023 | 4.82 Mn |
| Dec 31, 2022 | 5.47 Mn |
| Sep 30, 2022 | 5.05 Mn |
| Jun 30, 2022 | 9.24 Mn |
| Mar 31, 2022 | 10.97 Mn |
| Dec 31, 2021 | 14.61 Mn |
| Sep 30, 2021 | 18.70 Mn |
| Jun 30, 2021 | 19.84 Mn |
| Mar 31, 2021 | 31.02 Mn |
API Access
Regenxbio Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();